WeightWatchers CEO says the Ozempic era signals ‘the end of diet culture.’ Could we be so lucky?

For decades, companies like WeightWatchers, Jenny Craig, Nutrisystem, and Noom have made billions of dollars by preaching diets, exercise, “behavioral changes”—and above all, willpower. But now it’s much easier, and often more ef­fective, to just take a weekly shot of Ozempic, Wegovy, Mounjaro, or another so-called miracle drug. As customers embrace the pharma alternative to their traditional businesses, WeightWatchers and Noom are trying to pivot.

“We’re admitting that we’re learning; that the science has evolved—and therefore we should, as well,” WeightWatchers CEO Sima Sistani told me, about her company’s March deal to buy Sequence, a telehealth business that allows patients to obtain virtual prescrip­tions for the new weight-loss drugs. Two months later, Noom officially unveiled Noom Med, a similar telehealth platform.

I spoke with executives at both companies—as well as customers, doctors, analysts, and longtime diet-industry experts—for a new Fortune feature about the impact of the Ozempic era on the traditional weight-loss industry. Even Dr. Linda Anegawa, Noom’s chief medical officer, predicts, “We’re probably looking at the demise of dieting.”

Could we be so lucky? This is a business story, of course—WeightWatchers and Noom have both struggled financially in recent years, while 40-year-old Jenny Craig just shut down and then sold off its brand to Nutrisystem’s parent company—but it’s also a cultural and societal one.

Stuart Isett/Fortune

Anyone who’s ever had the joy of dieting knows how boring, hard, and emotionally fraught it is—and it’s also near-impossible to succeed long-term. The average dieter regains more than 80% of lost weight within five years, according to one meta-analysis of 29 long-term weight-loss studies. But those results haven’t kept the dieting industry from making billions of dollars, for years, by selling products that fundamentally aren’t permanent solutions.

So these business pivots raise plenty of outstanding questions about the Ozempic era’s long-term side effects—for investors and executives at WeightWatchers and Noom, for their (shrinking numbers of) employees, for their customers, and for society at large.

“I do see this as the end of diet culture. The focus has shifted from weight loss to weight health,” acknowledges Sistani, who became WeightWatchers CEO in 2022. However, she’s quick to argue that her 60-year-old company will always be an important part of achieving that new kind of health: “I want to be clear that the way you achieve it is through weight loss.”

Can she and her traditional diet-industry competitors succeed at threading this needle? Read the full feature here.

Maria Aspan
maria.aspan@fortune.com
@mariaaspan

The Broadsheet is Fortune’s newsletter for and about the world’s most powerful women. Subscribe here.

ALSO IN THE HEADLINES

- Barbie world. Greta Gerwig made history this weekend as Barbie earned $377 million at the global box office, the biggest debut ever for a female-directed film. Women moviegoers powered Gerwig to the record, accounting for 65% of ticket sales, according to PostTrak. The Guardian

- Captain of the ship. President Joe Biden has nominated Adm. Lisa Franchetti to lead the Navy. If she’s confirmed, Franchetti will be the first female U.S. military service chief and first woman to serve on the Joint Chiefs of Staff. AP

- DEI dies? The future of diversity, equity, and inclusion jobs is unclear as companies move away from DEI initiatives. Since last year, workers in the diversity field have been laid off by the thousands, while DEI executives at companies like Netflix and Disney are on their way out. Wall Street Journal

- Anti-woke avalanche. Texas A&M president Katherine Banks resigned last week as the fallout over the university’s hiring of journalist Kathleen McElroy snowballs. Banks said she takes responsibility for the messy contract negotiations that led McElroy, a former New York Times editor, to walk away from the role amid conservative backlash. Texas Tribune

MOVERS AND SHAKERS: Noorain Fatima Khan has been elected national board president of Girl Scouts of the USA.

IN CASE YOU MISSED IT

- Commentator draws penalty. An Australian commentator is under fire over comments he made about soccer powerhouse and recent mom Katrina Gorry during Australia’s first World Cup match last week. Commentator David Basheer has received stark criticism for saying that "motherhood has not blunted [Gorry's] competitive instincts." CNN

- Perfect isn't worth it. Nobody’s perfect, especially not in the workplace, but trying to achieve the unattainable standard can actually hurt you. Brooke Taylor, who coaches female executives at firms like Goldman Sachs, tells Fortune why perfectionism, people pleasing, and comparisons are “the biggest things that women at this level suffer.” Fortune

- Post-Roe. Thirteen Texas women were denied abortions despite having medical emergencies. Now, they’re suing the state to clarify what medical exceptions are valid, the first lawsuit to do so since Roe v. Wade was overturned. Vice

ON MY RADAR

This U.S. World Cup team is one for the ages. All the ages New York Times

Barbara Corcoran: This is the No. 1 quality that all ‘worthwhile employees’ share CNBC

Meet the queenagers: the new category of worker in your office that’s long been there Bloomberg

PARTING WORDS

"I want to be a farmer. I want to be a horse trainer. I want to own a Snickers factory—I love Snickers...it would be a disservice to my soul not to take advantage of that and do things that make me happy."

—Actress and comedian Tiffany Haddish on always trying new things